40 related articles for article (PubMed ID: 26405159)
1. Erratum: Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies.
Janku F; Angenendt P; Tsimberidou AM; Fu S; Naing A; Falchook GS; Hong DS; Holley VR; Cabrilo G; Wheler JJ; Piha-Paul SA; Zinner RG; Bedikian AY; Overman MJ; Kee BK; Kim KB; Kopetz ES; Luthra R; Diehl F; Meric-Bernstam F; Kurzrock R
Oncotarget; 2015 Sep; 6(27):24581. PubMed ID: 26405159
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive genomic profiling of relapsed and metastatic adenoid cystic carcinomas by next-generation sequencing reveals potential new routes to targeted therapies.
Ross JS; Wang K; Rand JV; Sheehan CE; Jennings TA; Al-Rohil RN; Otto GA; Curran JC; Palmer G; Downing SR; Yelensky R; Lipson D; Balasubramanian S; Garcia L; Mahoney K; Ali SM; Miller VA; Stephens PJ
Am J Surg Pathol; 2014 Feb; 38(2):235-8. PubMed ID: 24418857
[TBL] [Abstract][Full Text] [Related]
3. Emerging science and therapies in non-small-cell lung cancer: targeting the MET pathway.
Kris MG; Arenberg DA; Herbst RS; Riely GJ
Clin Lung Cancer; 2014 Nov; 15(6):475. PubMed ID: 25306384
[TBL] [Abstract][Full Text] [Related]
4. Targeted therapies and predictive markers in epithelial malignancies of the gastrointestinal tract.
McIntire M; Redston M
Arch Pathol Lab Med; 2012 May; 136(5):496-503. PubMed ID: 22229849
[TBL] [Abstract][Full Text] [Related]
5. Multigene profiling to identify alternative treatment options for glioblastoma: a pilot study.
Tabone T; Abuhusain HJ; Nowak AK; ; Erber WN; McDonald KL
J Clin Pathol; 2014 Jul; 67(7):550-5. PubMed ID: 24695838
[TBL] [Abstract][Full Text] [Related]
6. Profiling of actionable gene alterations in ovarian cancer by targeted deep sequencing.
Takenaka M; Saito M; Iwakawa R; Yanaihara N; Saito M; Kato M; Ichikawa H; Shibata T; Yokota J; Okamoto A; Kohno T
Int J Oncol; 2015; 46(6):2389-98. PubMed ID: 25846456
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between mutations of epidermal growth factor receptor in the plasma and pleural effusion and responses to gefitinib in advanced pretreated non-small cell lung cancer].
Guo J; Zhou C; Zhang J; Tang L
Zhongguo Fei Ai Za Zhi; 2007 Dec; 10(6):504-7. PubMed ID: 21129309
[TBL] [Abstract][Full Text] [Related]
8. Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment.
Nardi V; Sadow PM; Juric D; Zhao D; Cosper AK; Bergethon K; Scialabba VL; Batten JM; Borger DR; Iafrate AJ; Heist RS; Lawrence DP; Flaherty KT; Bendell JC; Deschler D; Li Y; Wirth LJ; Dias-Santagata D
Clin Cancer Res; 2013 Jan; 19(2):480-90. PubMed ID: 23186780
[TBL] [Abstract][Full Text] [Related]
9. Both human immunodeficiency virus cellular DNA sequencing and plasma RNA sequencing are useful for detection of drug resistance mutations in blood samples from antiretroviral-drug-naive patients.
Parisi SG; Boldrin C; Cruciani M; Nicolini G; Cerbaro I; Manfrin V; Dal Bello F; Franchin E; Franzetti M; Rossi MC; Cattelan AM; Romano L; Zazzi M; Andreoni M; Palù G
J Clin Microbiol; 2007 Jun; 45(6):1783-8. PubMed ID: 17442799
[TBL] [Abstract][Full Text] [Related]
10. From platinum compounds to targeted therapies in advanced thoracic malignancies.
Jakopovic M; Thomas A; Lopez-Chavez A
Anticancer Res; 2014 Jan; 34(1):477-82. PubMed ID: 24403504
[TBL] [Abstract][Full Text] [Related]
11. Potential clinical significance of a plasma-based KRAS mutation analysis in patients with advanced non-small cell lung cancer.
Wang S; An T; Wang J; Zhao J; Wang Z; Zhuo M; Bai H; Yang L; Zhang Y; Wang X; Duan J; Wang Y; Guo Q; Wu M
Clin Cancer Res; 2010 Feb; 16(4):1324-30. PubMed ID: 20145159
[TBL] [Abstract][Full Text] [Related]
12. Erratum.
Zhang J
J Anal Toxicol; 2015 Apr; 39(3):229-30. PubMed ID: 25656534
[TBL] [Abstract][Full Text] [Related]
13. [Analysis, identification and correction of some errors of model refseqs appeared in NCBI Human Gene Database by in silico cloning and experimental verification of novel human genes].
Zhang DL; Ji L; Li YD
Yi Chuan Xue Bao; 2004 May; 31(5):431-43. PubMed ID: 15478601
[TBL] [Abstract][Full Text] [Related]
14. Erratum to: Mutations of HNRNPA0 and WIF1 predispose members of a large family to multiple cancers.
Wei C; Peng B; Han Y; Chen WV; Rother J; Tomlinson GE; Richard Boland C; Chaussabel D; Frazier ML; Amos CI
Fam Cancer; 2015 Jun; 14(2):307. PubMed ID: 25820142
[No Abstract] [Full Text] [Related]
15. Resistance to targeted therapies against adult brain cancers.
Amer NA
Saudi Med J; 2019 Nov; 40(11):1179. PubMed ID: 31707419
[TBL] [Abstract][Full Text] [Related]
16. [Erratum to: Abstract-Band DOG 2015].
Deutsche Ophthalmologische Gesellschaft
Ophthalmologe; 2015 Oct; 112(10):870. PubMed ID: 26438433
[No Abstract] [Full Text] [Related]
17. Erratum: Abstract.
J Cancer Res Ther; 2020; 16(3):701. PubMed ID: 32719298
[No Abstract] [Full Text] [Related]
18. Incorrect Data in the Abstract and Conclusion.
JAMA; 2015 Oct; 314(15):1647. PubMed ID: 26501548
[No Abstract] [Full Text] [Related]
19. Erratum.
Ijkd E
Iran J Kidney Dis; 2021 May; 15(3):242. PubMed ID: 33994386
[TBL] [Abstract][Full Text] [Related]
20. Incorrect Percentages in the Abstract.
JAMA Oncol; 2017 Dec; 3(12):1742. PubMed ID: 29145564
[No Abstract] [Full Text] [Related]
[Next] [New Search]
